Stock Analiz

Immunome Inc. (IMNM) stock forecast and price target

Price $18.77 · data as of November 13, 2026

12-month price target

Average target$35.13
Upside / downside+87.2%
Analysts15
ConsensusStrong buy
Low $23.00Average $35.13High $40.00

Gold marker: average target · white marker: today’s price ($18.77)

Analyst ratings

Strong buy 3Buy 13Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.50−3.0%$0
Next fiscal year
ends December 31, 2027
$-2.55−1.8%$50M
Next quarter
ends December 31, 2026
$-0.60+21.1%$0
Quarter after
ends December 31, 2026
$-0.74+2.2%$0

Consensus of the analysts covering Immunome, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.

Frequently asked questions

What is the Immunome stock price target?

The average 12-month target from 15 analysts is $35.13, 87.2% above the current price of $18.77 Targets range from $23.00 to $40.00.

Is Immunome a buy according to analysts?

The consensus rating is “Strong buy” (3 strong buy, 13 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Immunome expected to earn?

Analysts expect EPS of $-2.50 for the fiscal year ending December 31, 2026 and $-2.55 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.